363 related articles for article (PubMed ID: 19772270)
1. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Walsman S; Modi A
Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
[TBL] [Abstract][Full Text] [Related]
2. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation.
Montero JA; Ruiz-Moreno JM; Sanabria MR; Fernandez-Munoz M
Br J Ophthalmol; 2009 Feb; 93(2):166-70. PubMed ID: 18971240
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
Retina; 2006; 26(6):602-12. PubMed ID: 16829800
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
Sutter FK; Kurz-Levin MM; Scherrer M; Barthelmes D; Fleischhauer JC; Helbig H
Klin Monbl Augenheilkd; 2007 Apr; 224(4):297-9. PubMed ID: 17458796
[TBL] [Abstract][Full Text] [Related]
6. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
Jonas JB; Degenring RF; Kreissig I; Friedemann T; Akkoyun I
Eye (Lond); 2005 Feb; 19(2):163-70. PubMed ID: 15218517
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
8. Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP).
Sutter FK; Kurz-Levin MM; Fleischhauer J; Bösch MM; Barthelmes D; Helbig H
Klin Monbl Augenheilkd; 2006 May; 223(5):376-8. PubMed ID: 16705508
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
Ruiz-Moreno JM; Montero JA; Zarbin MA
Retina; 2007; 27(4):458-61. PubMed ID: 17420698
[TBL] [Abstract][Full Text] [Related]
10. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
[TBL] [Abstract][Full Text] [Related]
11. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
12. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Harder B
Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
[TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
14. Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B
Ophthalmic Res; 2006; 38(6):324-8. PubMed ID: 17047404
[TBL] [Abstract][Full Text] [Related]
15. [Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD. Introductory report].
Mozolewska-Piotrowska K; Krzystolik K; Karczewicz D; Drobek-Słowik M; Kubasik-Kładna K
Klin Oczna; 2011; 113(7-9):233-6. PubMed ID: 22256564
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Jonas JB; Akkoyun I; Budde WM; Kreissig I; Degenring RF
Arch Ophthalmol; 2004 Feb; 122(2):218-22. PubMed ID: 14769599
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients.
Ito M; Okubo A; Sonoda Y; Yamakiri K; Sakamoto T
Ophthalmologica; 2006; 220(2):118-24. PubMed ID: 16491035
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide].
Lubiński W; Gosławski W; Mozolewska-Piotrowska K; Szych Z; Karczewicz D
Ann Acad Med Stetin; 2008; 54(1):22-7; discussion 27. PubMed ID: 19127806
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
